Atlas Trials

Patients Treated in Real Life With VEnetoclax for WAldenström Macroglobulinemia

Clinical trial NCT06200220 · UNKNOWN

Trial details

NCT number
NCT06200220
Sponsor
Poitiers University Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Waldenstrom's Macroglobulinaemia Refractory
Start date
2023-12-28
Primary completion
2023-12-28
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.